162 related articles for article (PubMed ID: 23866593)
1. [Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies].
Proletov IaIu; Saganova ES; Galkina OV; Zubina IM; Bogdanova EO; Sipovskiĭ VG; Smirnov AV
Ter Arkh; 2013; 85(6):10-6. PubMed ID: 23866593
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
[TBL] [Abstract][Full Text] [Related]
3. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
[TBL] [Abstract][Full Text] [Related]
4. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
[TBL] [Abstract][Full Text] [Related]
6. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
9. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
Yang YH; He XJ; Chen SR; Wang L; Li EM; Xu LY
Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
[TBL] [Abstract][Full Text] [Related]
10. Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study.
Di Nardo M; Ficarella A; Ricci Z; Luciano R; Stoppa F; Picardo S; Picca S; Muraca M; Cogo P
Blood Purif; 2013; 35(1-3):172-6. PubMed ID: 23428967
[TBL] [Abstract][Full Text] [Related]
11. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.
Sola-Del Valle DA; Mohan S; Cheng JT; Paragas NA; Sise ME; D'Agati VD; Barasch J
Nephrol Dial Transplant; 2011 Jul; 26(7):2387-90. PubMed ID: 21555394
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.
Duan SB; Pan P; Xu Q; Li X; Liu N; Xu J
Ren Fail; 2014 Oct; 36(9):1407-10. PubMed ID: 25246341
[TBL] [Abstract][Full Text] [Related]
13. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
[TBL] [Abstract][Full Text] [Related]
15. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neutrophil gelatinase-associated lipocalin, interleukin-18, and cystatin C as molecular markers before and after unilateral shock wave lithotripsy.
Kardakos IS; Volanis DI; Kalikaki A; Tzortzis VP; Serafetinides EN; Melekos MD; Delakas DS
Urology; 2014 Oct; 84(4):783-8. PubMed ID: 25135871
[TBL] [Abstract][Full Text] [Related]
17. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies].
Saganova ES; Zubina IM; Bogdanova EO; Galkina OV; Sipovskii VG; Smirnov AV
Ter Arkh; 2021 Jun; 93(6):699-705. PubMed ID: 36286837
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
